MedTrace Logo

AmbassADDOrs for Health Study

NCT05357144 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2026-04-09

No results posted yet for this study

Summary

The goal of the study is to evaluate Malkia Klabu ("Queen Club") in Tanzania, a loyalty program intervention that creates adolescent girls and young women (AGYW)-friendly drug shops where AGYW can access HIV prevention services and contraception.

Conditions

  • HIV Infections

Interventions

BEHAVIORAL

Loyalty card program at drug shops & supply of HIVST and SRH products

Consenting drug shops will receive: * training on Malkia Klabu implementation; * HIVST training (same as comparison drug shops); * procedures for referring to youth-friendly HIV/SRH services; * a monthly supply of HIVST reserved for free distribution to AGYW, with "free" price stickers and pre-packaged with referral information; and * reimbursement for SRH products given to AGYW (e.g., birth control pills).

BEHAVIORAL

Comparison drug shops

Consenting drug shops in the comparison arm catchment areas will have access to the Maisha Meds inventory management application system for offline digital recording of HIVST, HIVST kits earmarked for free to AGYW, guidance on HIV care referral plan to facilitate linkage to nearby health facilities for AGYW. These control drug shops will not participate in Malkia Klabu (Queen Club) program implementation.

Sponsors & Collaborators

Principal Investigators

  • Jenny X Liu, PhD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-26
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Tanzania

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05357144 on ClinicalTrials.gov